Subscribe: Market Wire - Pharmaceuticals and Biotech: Biotech
http://img.marketwire.com/rss/mwPBBI.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announced  announces  apr  april  cannabis  company  marketwired apr  marketwired april  marketwired  new  today announced  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Pharmaceuticals and Biotech: Biotech

Marketwired - Biotech



Marketwired - Biotech



Last Build Date: Tue, 25 Apr 2017 21:12:38 EDT

Copyright: Copyright: (C) Marketwired
 



Zecotek Announces Non-Brokered Private Placement

Tue, 25 Apr 2017 19:44:56 EDT

SINGAPORE--(Marketwired - April 25, 2017) -




Model N Kicks Off Rainmaker 2017, The Premier Revenue Management Conference

Tue, 25 Apr 2017 18:10:00 EDT

Former Vermont Gov. Howard Dean, former Oklahoma Sen. Tom Coburn and industry experts discuss key trends and strategies for Revenue Management as a Service (RMaaS)




Triumvira to Present Corporate Update at the Bloom Burton & Co. Healthcare Investor Conference

Tue, 25 Apr 2017 17:30:00 EDT

HAMILTON, ON and HACKENSACK, NJ--(Marketwired - April 25, 2017) - Triumvira Immunologics Inc. today announced that its President and Chief Executive Officer Tony Fiorino, MD, PhD, will present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference taking place May 1 and 2, 2017 at the Sheraton Centre Toronto Hotel, Toronto, Canada. Triumvira is scheduled to present on Tuesday, May 2 at 3:00PM ET in Sheraton Hall B.




Chiesi USA Sponsors the Triangle March for Babies Walk & 5K Run

Tue, 25 Apr 2017 17:19:53 EDT

The community is invited to walk and support March of Dimes efforts




Oticon Opn(TM) Brings Home the Gold at the 2017 Edison Awards

Tue, 25 Apr 2017 14:57:21 EDT

And Adds 2017 Red Dot Award to Opn's Growing List of International Awards




ProSolus Seeks Higher Utilization of Transdermal Drug Delivery Technology

Tue, 25 Apr 2017 14:38:23 EDT

Parent company, Mission Pharmacal, expands commitment to patch technology with significant investments in manufacturing and commercial team




EAG Laboratories Expands Cell Bioassay Laboratory to Enhance Biopharmaceutical Development Service Offering

Tue, 25 Apr 2017 12:58:57 EDT

SAN DIEGO, CA--(Marketwired - Apr 25, 2017) -  EAG Laboratories, a global scientific services company that provides testing, analytical and characterization services to technology- and life-science-related industries, announced that the company is adding to its biopharmaceutical development capabilities by expanding a dedicated cell bioassay laboratory in Columbia, Missouri. The announcement follows several recent investments made to support its growing life sciences customer base.




YO(TM) Home Sperm Test Participates in National Infertility Awareness Week

Tue, 25 Apr 2017 11:07:02 EDT

The first FDA cleared Smartphone based technology for male fertility testing is encouraging men to dive in and test their swimmers




3M Health Information Systems Renews HFMA Peer Review Designation

Tue, 25 Apr 2017 11:00:00 EDT

CHICAGO, IL--(Marketwired - April 25, 2017) - The Healthcare Financial Management Association (HFMA) today announced that, following rigorous review, 3M Health Information Systems has once again achieved the "Peer Reviewed by HFMA®" designation for its 3MT DRG Assurance Program service.




Cannabis Science 2017 Black Tie Gala for Cannabinoid Research Targeting Critical Ailments, Testimonials, Celebrity Interests, New Partnerships, and Loyalty Gift to Shareholders

Tue, 25 Apr 2017 09:00:26 EDT

IRVINE, CA--(Marketwired - Apr 25, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce updates to its 2017 Gala. The venue has been narrowed down to a short list in Beverly Hills/Hollywood area of Los Angeles, California with a proposed target date in the third quarter of this year. The Black-Tie Event will be open to the company's stakeholders, will host strategic partners, celebrities, researchers, and a plethora of unique events and keynote speakers. One of the key announcements at the event will be the long-awaited shareholder loyalty gift from the President & CEO, Mr. Dabney to the Company's many loyal shareholders.




Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2017

Tue, 25 Apr 2017 09:00:00 EDT

SALT LAKE CITY, UT--(Marketwired - Apr 25, 2017) - In the first calendar quarter (1Q) of 2017, Utah Medical Products, Inc. (NASDAQ: UTMD) achieved results representing a strong start to achieving its financial goals for year 2017.




4th annual Regenerative Medicine Essentials Course to be held in June in Winston-Salem, NC

Tue, 25 Apr 2017 09:00:00 EDT

WINSTON-SALEM, NC--(Marketwired - April 25, 2017) - The fourth annual Regenerative Medicine Essentials Course will be held June 5 - 9 in downtown Winston-Salem. The course is made possible through the collaborative partnership between the Regenerative Medicine Foundation (RMF) and the Wake Forest Institute for Regenerative Medicine (WFIRM).




FDA Grants Diazyme 510(k) Clearance to Market Its Procalcitonin Assay for Clinical Chemistry Analyzers

Tue, 25 Apr 2017 09:00:00 EDT

SAN DIEGO, CA--(Marketwired - April 25, 2017) - Diazyme Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market its Procalcitonin (PCT) assay. Procalcitonin, a propeptide synthesized in the C-cells of the thyroid, has been identified to be more clinically useful and superior than currently used common clinical variables and laboratory tests in the diagnosis of sepsis. PCT is ubiquitously and uniformly expressed in multiple tissues throughout the body. In healthy conditions, PCT levels in circulation are very low. Rising PCT concentrations can be detected within 2 - 6 hours after infectious challenges and peak within 6 - 24 hours. Once an infection is under control, PCT levels decrease. This rapid response is highly specific to bacterial infections and has made PCT one of the most pertinent biomarkers used in detecting bacterial infection or sepsis.




Treos Bio Names Group of Leading Clinical and Regulatory Experts to Clinical Advisory Board

Tue, 25 Apr 2017 08:15:00 EDT

Members' deep expertise will guide company as it advances its pipeline into clinical trials




VIVUS Announces Date of 2017 First Quarter Business Update and Financial Results Teleconference

Tue, 25 Apr 2017 08:00:00 EDT

CAMPBELL, CA--(Marketwired - April 25, 2017) - VIVUS, Inc. (NASDAQ: VVUS) today announced that it will report financial results and provide a business update for the first quarter of 2017 after the NASDAQ Market closes on Wednesday, May 3, 2017. The company will conduct a conference call and an audio webcast at 4:30 pm ET the same day.




BioVie Signs Cooperative Research and Development Agreement (CRADA) to Conduct a Phase 2a Clinical Trial of BIV201 in Refractory Ascites Patients

Tue, 25 Apr 2017 08:00:00 EDT

BEVERLY, MA--(Marketwired - April 25, 2017) - BioVie Inc. (OTCQB: BIVI), a clinical-stage company focused on the discovery, development, and commercialization of innovative drug therapies for liver disease, today announced the signing of a Cooperative Research and Development Agreement (CRADA) to conduct a Phase 2a clinical trial of BIV201 in patients with refractory or intractable ascites due to advanced liver cirrhosis. The study is titled: Safety and pharmacodynamic activity of low-dose terlipressin delivered by continuous intravenous infusion in patients with cirrhosis and refractory ascites requiring recurrent large volume paracentesis."




InCrowd Captures Market Momentum with Three New Hires

Tue, 25 Apr 2017 08:00:00 EDT

With Its New Automated Solutions for Qualitative Research, Tracking Studies Driving Strong Q1 2017 Results, InCrowd's New Leaders Will Help Accelerate Company's Growth




DiaMedica Announces Dr. Nancy Chang to its Strategic Advisory Board

Tue, 25 Apr 2017 08:00:00 EDT

MINNEAPOLIS, MINNESOTA--(Marketwired - April 25, 2017) - DiaMedica Therapeutics Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) is pleased to announce the addition of Dr. Nancy Chang to its Strategic Advisory Board to support the Company's development of its lead product, DM199. Dr. Chang brings more than 30 years of experience in the biopharmaceutical industry, successfully developing and commercializing therapeutic and diagnostic products. She is the co-founder of Tanox, Inc., a biotechnology company known for the development of Xolairâ, the breakthrough drug which changed the treatment model for allergy-induced asthma. Dr. Chang served as President and CEO of Tanox until its acquisition in 2007 by Genentech for US$919 million.




Half of Pharma Global Teams' Pharmacovigilance Funding is Contributed by a Standalone Drug Safety Team

Tue, 25 Apr 2017 07:30:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - April 25, 2017) - On average, half (50%) of surveyed global teams' pharmacovigilance funding is contributed by a standalone drug safety team, according to data published by industry intelligence provider Cutting Edge Information.




Upcoming Webinar to Examine Implementing Basket/Bucket and Umbrella Designs: What You Need to Know for Global Oncology Trials

Tue, 25 Apr 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - April 25, 2017) - On Monday, May 8, 2017, Xtalks will host a complimentary webinar with a panel of speakers from Covance, featuring: Amy Franke, Senior Director of Strategy and Planning, Bridget (Fitzsimmons) Weeks, Director of Project Management (Oncology) and Montessa Lizaso, Senior Data Analyst for Strategy and Planning (Oncology).




Outcomes-Based Agreements and Innovative Contracting for Biopharmaceuticals: Where Is The Market Moving?, New Webinar Hosted by Xtalks

Tue, 25 Apr 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - April 25, 2017) - During a live broadcast on Wednesday, May 10, 2017, industry expert Janice Watch, Divisional Principal, Head of EU Pricing and Market Access from ICON Commercialisation and Outcomes will provide a deeper understanding of the changing contracting landscape and to learn ways to leverage new and innovative approaches to improve the commercial success of your biopharmaceutical products.




biOasis Appoints Mark Day, Ph.D., as Chief Executive Officer and Director

Mon, 24 Apr 2017 17:07:00 EDT

VANCOUVER, BC--(Marketwired - April 24, 2017) -




Quidel Reports First Quarter 2017 Financial Results

Mon, 24 Apr 2017 16:10:00 EDT

SAN DIEGO, CA--(Marketwired - April 24, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the first quarter ended March 31, 2017.




Corcept Therapeutics to Announce First Quarter Financial Results and Corporate Update and Host Conference Call

Mon, 24 Apr 2017 16:05:00 EDT

MENLO PARK, CA--(Marketwired - Apr 24, 2017) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update on May 1, 2017. The Company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).




Tetra Bio-Pharma Accelerates Sales Strategy with the Appointment of Denis Courchesne as Vice President, Sales

Mon, 24 Apr 2017 16:00:00 EDT

OTTAWA, ONTARIO--(Marketwired - April 24, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE:TBP) (OTCQB:GRPOF), today announced that it has accelerated its sales strategy by entering into an employment agreement with Denis Courchesne as Vice President, Sales, effective Monday, May 1, 2017.




Harvest One Announces Conditional Approval of Acquisition of ACMPR Licensed Medical Cannabis Producer and Swiss Medical Cannabis-Based Health Products Company

Mon, 24 Apr 2017 15:11:37 EDT

TORONTO, ONTARIO--(Marketwired - April 24, 2017) -




Intergraph(R) releases CADWorx(R) Structure 2017 R1 with advanced new 3D steel structure design capabilities

Mon, 24 Apr 2017 12:33:08 EDT

HOUSTON, TX--(Marketwired - Apr 24, 2017) - Intergraph announces the release of CADWorx® Structure 2017 R1, a fit-for-purpose solution for designing steel structures and modeling industrial plant buildings, pipe racks, offshore topsides and other structures for process, power and manufacturing facilities. This release adds the option to run on the AutoCAD® or BricsCAD® platform and provides new advanced capabilities that allow designers and engineers to cite the weight and center of gravity of objects to determine if they can be lifted and transported, export to a detailing tool or structural analysis program by using a CIS/2 file, place gusset plates and connect them to bracing to avoid routing objects through an area, and add openings to any structural object. The release also allows users to annotate structural objects to include a short and long description, part number and tag, material and member size and other details.




Science Exchange Invited to Speak at the 20th Annual Milken Institute Global Conference 2017

Mon, 24 Apr 2017 11:00:00 EDT

Elizabeth Iorns, Ph.D., Founder and CEO of Science Exchange, joins panel to discuss how today's young entrepreneurs are reshaping the biopharma business model




Easton Pharmaceuticals Announces Signing NDA and Starts Negotiations For Acquisition

Mon, 24 Apr 2017 10:19:05 EDT

Joint Venture With Producer of Crop Protection, Fertilizer and Plant Wash Products Company Vital for Medical Marijuana and Other Agricultural Uses




Aequus to Present at Bloom Burton & Co. Healthcare Investor Conference

Mon, 24 Apr 2017 09:30:00 EDT

VANCOUVER, BC--(Marketwired - April 24, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today announced that its Chairman and Chief Executive Officer, Doug Janzen, will present at the sixth annual Bloom Burton & Co. Healthcare Investor Conference on Monday May 1st, 2017 at 3:00pm Eastern Daylight Time at the Sheraton Centre Toronto Hotel in Toronto, Ontario.




eWellness Executes PHZIO Beta User Agreement with Jackson Clinics

Mon, 24 Apr 2017 09:00:00 EDT

CULVER CITY, CA--(Marketwired - Apr 24, 2017) - eWellness Healthcare Corporation (OTCQB: EWLL), a provider of the state of the art PHZIO Platform for the physical therapy and telehealth markets, announced today that it has executed a 90-day PHZIO beta user agreement with Jackson Clinics, LP, which has 15 clinics located in Northern Virginia, https://thejacksonclinics.com.




Therapeutic Solutions International's Subsidiary OmniBiome, Inc. Announces First Oral Microbiome Therapy for Periodontal Disease

Mon, 24 Apr 2017 09:00:00 EDT

Company Files Patent and Obtains Proof of Concept Data on Late David Palella's Vision of Scientifically Driven Microbiome Modulatory Consumer Products




TrendMiner Software is being rolled out by Total's Refining & Chemicals Segment

Mon, 24 Apr 2017 08:30:00 EDT

TrendMiner predictive analytics software selected by Total to facilitate self-service analytics and process performance optimization of its Refining & Chemicals segment




Advantis Corp. Co-Brands, Launches Natural Elements Tea

Mon, 24 Apr 2017 08:30:00 EDT

NEWPORT BEACH, CA--(Marketwired - Apr 24, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) is launching the co-branded line of Natural Elements Teas this week.




Lion Biotechnologies to Host Conference Call to Discuss First Quarter 2017 Financial and Operating Results on Monday, May 1, 2017

Mon, 24 Apr 2017 08:00:00 EDT

SAN CARLOS, CA--(Marketwired - April 24, 2017) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it will report its first quarter 2017 financial and operating results after the close of the U.S. financial markets on Monday, May 1, 2017. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 5:00 p.m. ET.




SpeeDx and Thermo Fisher Scientific Announce Strategic Partnership for FDA Clearance of Molecular Diagnostic

Mon, 24 Apr 2017 08:00:00 EDT

ResistancePlus(TM) MG Test would bring disease and antibiotic resistance testing to U.S. market for sexually transmitted infection and potential "superbug"




ORYZON Announces New Grant from Alzheimer's Drug Discovery Foundation (ADDF) to develop a companion marker for its ORY-2001 epigenetic drug

Mon, 24 Apr 2017 08:00:00 EDT

ADDF to increase its stake in the company to reach 0.77 % of the common stock







BioSyent to Present at 2017 Bloom Burton & Co. Healthcare Investor Conference

Mon, 24 Apr 2017 08:00:00 EDT

TORONTO, ONTARIO--(Marketwired - April 24, 2017) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that it will be presenting at the upcoming Bloom Burton & Co. Healthcare Investor Conference on May 1st, 2017 at 3:00pm ET at the Sheraton Centre Toronto Hotel, Toronto, Ontario. Mr. René Goehrum, President and CEO, will present to investors an overview of BioSyent's business and corporate activities. Mr. Goehrum will also be available to meet with investors on a one-on-one basis during the conference on May 1st and 2nd. These one-on-one meetings can be requested by attendees through the online conference portal: http://www.bloomburton.com/conference/.




IBEX announces stock option grant to directors and officers

Mon, 24 Apr 2017 08:00:00 EDT

MONTREAL, QUEBEC--(Marketwired - April 24, 2017) - IBEX Technologies Inc. ("IBEX" or the "Company") (TSX VENTURE:IBT) today announced that on April 21, 2017 the Company's Board of Directors granted stock options representing a total of 105,000 common shares to certain of its directors and officers.




Nephros Announces Partnership with WorldWater & Solar Technologies

Mon, 24 Apr 2017 07:31:02 EDT

RIVER EDGE, NJ--(Marketwired - Apr 24, 2017) -  Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, and WorldWater & Solar Technologies, Inc., a leader in integrated solar platform technology that uses sunshine to drive motors and pumps in large-scale irrigation and municipal water delivery systems, jointly announced today that they have signed a partnership agreement to incorporate Nephros ultrafilters into their solar powered drinking water systems.




Upcoming Webinar to Optimise Your Medical Publications and Avoid "Predatory Journals"

Mon, 24 Apr 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - April 24, 2017) - On Tuesday, May 9, 2017, join a panel of industry experts to learn tips and tools to enhance your medical publication efforts and avoid so-called "predatory journals". Jeffrey Beall, Scholarly Communications Librarian and Associate Professor at the University of Colorado Denver, and ICON's PubsHub team will discuss the growth of open access publishing and what precautions you can take to avoid falling into costly and career damaging traps. Learn best practices and tools to:




Turning Biorepositories into Translational Science Treasure Troves, New Webinar Hosted by Xtalks

Mon, 24 Apr 2017 07:00:00 EDT

The Value of Uniquely Complete Data Sets, Put All Your Specimens -- and All of Their Data -- At Your Fingertips System




Akers Biosciences Updates on Akers Wellness(TM) Tests

Mon, 24 Apr 2017 07:00:00 EDT

Akers Wellness iOS digital application approved by the Apple App Store




Amedica Announces Regulatory Clearance to Market and Sell Valeo(R) Silicon Nitride Spinal Implants in Australia

Mon, 24 Apr 2017 07:00:00 EDT

Australian Marketing Clearance Provides Opportunities for Global Expansion




Med Ad News Recognizes Healthcare Communications Excellence At 2017 Manny Awards

Fri, 21 Apr 2017 15:27:14 EDT

LIVINGSTON, NJ--(Marketwired - April 21, 2017) - Med Ad News -- the leading pharmaceutical business and marketing publication -- announces the winners for the 2017 Manny Awards, celebrating the best in the healthcare communications industry. The black-tie gala affair occurred last night at Pier Sixty in New York City with 500-plus people in attendance. Twenty awards were bestowed throughout the night to healthcare agencies achieving excellence in various categories.




Positive Annual Financial Results for Vivakor

Fri, 21 Apr 2017 13:24:56 EDT

LAS VEGAS, NV--(Marketwired - April 21, 2017) - Vivakor Inc. (OTC PINK: VIVK) announced GAAP based financial results for the quarter ended December 31, 2016.




Cannabis Science Continues Expansions as it Negotiates to Acquire Two Medical Marijuana Dispensaries in Los Angeles, California; The Company Expects to Sign Closing Documents Shortly

Fri, 21 Apr 2017 12:12:22 EDT

CBIS Negotiates for Two Los Angeles, California Medical Marijuana Dispensaries Right Before the Global Health Catalyst Summit at Harvard




Clinical Ink Extends eCOA and Risk-Based Monitoring Capabilities

Fri, 21 Apr 2017 12:00:00 EDT

Latest SureSource(R) Release Expands eSource Functionality and Platform Interoperability




Rennova Health's Big South Fork Medical Center Moves Closer to Opening

Fri, 21 Apr 2017 08:30:00 EDT

WEST PALM BEACH, FL --(Marketwired - April 21, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announced today that the Centers for Medicare and Medicaid Services (CMS) has concluded its review of the application submitted by its subsidiary Big South Fork Medical Center (Legal Name: Scott Community Hospital, Inc.) requesting enrollment in the Medicare program as a Hospital. CMS has confirmed that it has issued a recommendation for approval to the Tennessee State Agency and the CMS Regional Office (RO).




Mount Tam Biotechnologies Announces that the European Patent Office Has Allowed a Key Patent for Lead Compound TAM-01

Fri, 21 Apr 2017 06:00:00 EDT

NOVATO, CA--(Marketwired - Apr 21, 2017) - Mount Tam Biotechnologies, Inc. ("Mount Tam") (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased to announce that the European Patent Office has allowed a key patent for TAM-01, a novel mTOR modulator, targeting unmet need in systemic lupus erythematosus (SLE). The patent, owned by the Buck Institute for Research on Aging and licensed exclusively to Mount Tam Biotechnologies, provides composition of matter protection for Mount Tam's lead compound in Europe, further strengthening Mount Tam's strong intellectual property position in the United States and Japan.




InMed Pharmaceuticals Announces Marketed Offering of Common Shares

Fri, 21 Apr 2017 05:30:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 21, 2017) -




Vernalis PLC: FDA Issues a Complete Response Letter on CCP-07 NDA

Fri, 21 Apr 2017 02:00:00 EDT

WINNERSH, UNITED KINGDOM--(Marketwired - Apr 21, 2017) - Vernalis PLC (LSE: VER)




Aevi Genomic Medicine Presents Updated Results from SAGA Trial of AEVI-001 at the 6th World Congress on ADHD

Thu, 20 Apr 2017 16:30:00 EDT

PHILADELPHIA, PA--(Marketwired - Apr 20, 2017) -




Sirona Biochem Receives TSX Venture Exchange Approval on Warrant Extension

Thu, 20 Apr 2017 16:22:45 EDT

VANCOUVER, BC--(Marketwired - April 20, 2017) - Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) (XETRA: ZSB) announces an extension to the term of 8,850,770 common share purchase warrants (the "Warrants") originally issued on March 6, 2014. The warrants were issued as part of a private placement. The expiry dates will be extended as follows:




BioSyent Extends In-License Agreement for Cathejell(R)

Thu, 20 Apr 2017 16:00:00 EDT

TORONTO, ONTARIO--(Marketwired - April 20, 2017) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. ("BioSyent Pharma"), has extended its License, Distribution and Supply Agreement with its European partner, Pharmazeutische Fabrik Montavit Ges.m.b.H., which gives BioSyent Pharma exclusive Canadian rights to the Cathejell® Jelly 2% product until March 31, 2024.




Avantor Acquires Puritan Products

Thu, 20 Apr 2017 15:30:00 EDT

Acquisition bolsters Avantor's portfolio of high-purity cGMP materials and solutions for Biopharma, Research and Electronic Materials customers




World's Largest Society for Regulatory Professionals Increases Investment in Europe

Thu, 20 Apr 2017 14:00:30 EDT

ROCKVILLE, MD and NEWCASTLE UPON TYNE, UNITED KINGDOM--(Marketwired - April 20, 2017) - The Regulatory Affairs Professionals Society (RAPS) is stepping up its presence in Europe and expanding its European team in response to growing membership demand from those involved with the regulation of healthcare and related products.




Former Megaupload Programming Team Joins mCig, Inc. in the Cannabis Tech Space

Thu, 20 Apr 2017 12:17:53 EDT

HENDERSON, NV--(Marketwired - Apr 20, 2017) - mCig, Inc., (OTCQB: MCIG) a leading distributor of innovative products, technologies and services for the global medical marijuana industry, is pleased to announce the achievement of acquiring part of the former Megaupload development team. The team is led by Chief Technologist, Andrus Nomm, recognized as the senior operative and programming lead in the popular online file sharing, streaming and ad serving websites of MEGAupload, MEGAclick and MEGAvideo. The sites served approximately 50 million users per day over 6500+ servers, monetizing over a quarter billion USD in advertising and subscription revenue. 




Ogilvy CommonHealth Worldwide strengthens its creative offering with executive-level new hire and promotions

Thu, 20 Apr 2017 11:26:36 EDT

PARSIPPANY, NJ--(Marketwired - Apr 20, 2017) - Ogilvy CommonHealth Worldwide (www.ogilvychww.com), the health behavior change specialists of Ogilvy & Mather (www.ogilvy.com) and a WPP Health & Wellness company (NASDAQ: WPPGY) (www.wpp.com), today announced one new hire and three promotions at the executive vice president, creative director level in the network's New Jersey headquarters.




Cannabis Science Issues First Quarter Update and Celebrates 4/20 With Unprecedented Revenue Growth Projections and Sustainable Equity Value Looking Forward to More Quarterly Growth and Progress Reports

Thu, 20 Apr 2017 11:18:02 EDT

IRVINE, CA--(Marketwired - Apr 20, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, recently announced a pending offering memorandum for expansion capital, another large drug development deal, and an expedited seeding schedule, all of which are expected to create sustainable equity value and unprecedented revenue growth for the company.




Propanc CEO James Nathanielsz's FDA Policy Proposals Published in Pharma Trade Media

Thu, 20 Apr 2017 10:07:05 EDT

Company completes 1-for-250 reverse split and name change to Propanc Biopharma Inc.




OncBioMune Licenses Tretinoin for the Treatment of Acute Promyelocytic Leukemia Throughout Mexico, Central and Latin America

Thu, 20 Apr 2017 09:31:40 EDT

BATON ROUGE, LA--(Marketwired - April 20, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a proprietary vaccine technology, is pleased to announce the signing of a licensing agreement between the Company and PROCAPS S.A.S. granting OncBioMune rights to tretinoin, also known as all-trans retinoic acid (ATRA), an oral drug for the treatment of Acute Promyelocytic Leukemia (APL), throughout Mexico, Central America and Latin America.




Aphria Raises $100 Million to Fund Continued Expansion of Production Capacity and Other Strategic Opportunities

Thu, 20 Apr 2017 09:15:21 EDT

LEAMINGTON, ONTARIO--(Marketwired - April 20, 2017) -




MyDx Releases Earnings Call Investor Presentation

Thu, 20 Apr 2017 09:00:00 EDT

Invites Industry and Media to Learn More About MyDx Breakthrough Technology Setting the Foundation for the Future of Cannabis




BioElectronics President Interviewed By UpTick Radio: A Discussion on how Wearable Technology can Mitigate the Opioid Addiction Crisis

Thu, 20 Apr 2017 08:30:00 EDT

FREDERICK, MD--(Marketwired - Apr 20, 2017) - BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, over-the-counter pain management devices. The company manufactures and markets its flagship product, ActiPatch® Chronic Musculoskeletal Pain Therapy as a drug-free, wearable nonprescription medical device that provides 720-hours of on/off therapy. The president of BioElectronics, Andrew Whelan was interviewed by UpTick Radio about the ActiPatch technology. The full transcript is available at (https://upticknewswire.com/wp-content/uploads/2017/04/Uptick-Network-BIEL-Interview-04-13-17.mp3)




Atossa Genetics Receives Positive Interim Review From Independent Safety Committee in Phase 1 Endoxifen Dose Escalation Study

Thu, 20 Apr 2017 08:15:00 EDT

SEATTLE, WA--(Marketwired - Apr 20, 2017) -  Atossa Genetics, Inc. (NASDAQ: ATOS), a clinical-stage pharmaceutical company, today announced that it has received a positive interim review on its Phase 1 study of endoxifen, which is an active metabolite of the FDA approved drug tamoxifen, which is indicated for breast cancer and breast cancer prevention in high risk patients. The Independent Safety Committee reviewed the blinded data generated from the first cohort of the study (8 subjects) and concluded that the study may advance to the next dosing level.




Vitality Biopharma Releases Clinical Report of Cannabinoid Therapy for Pediatric IBD

Thu, 20 Apr 2017 08:00:00 EDT

Cannabinoid therapy was able to successfully induce and maintain long-term remission in case study of drug-resistant pediatric inflammatory bowel disease




Easton Pharmaceuticals Announces Signing Of Purchase Agreement Completing The Acquisition Of Revenue Producing Vaporizer and e-Liquids Manufacturer iBliss, Inc.

Thu, 20 Apr 2017 08:00:00 EDT

TORONTO, ON--(Marketwired - Apr 20, 2017) - Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) is pleased to announce the execution of final agreement completing the 100% acquisition of revenue generating vaporizer and e-liquids manufacturer, iBliss Inc. and its holding company.




Aldeyra Therapeutics, Inc. Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-102 in Sjögren-Larsson Syndrome

Thu, 20 Apr 2017 08:00:00 EDT

LEXINGTON, MA--(Marketwired - Apr 20, 2017) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a clinical-stage biotech company devoted to treating diseases thought to be related to endogenous aldehydes, a naturally occurring class of pro-inflammatory and toxic molecules, today announced that the United States Food and Drug Administration (FDA) has granted Aldeyra's novel compound ADX-102 orphan drug designation for the treatment of congenital ichthyosis, a severe skin disease characteristic of Sjögren-Larsson Syndrome (SLS). There are no FDA-approved therapies specifically indicated for the treatment of SLS, and ADX-102 is believed to be the only potential SLS therapy in clinical development.




Glybera Marketing Authorization Application Withdrawn In Europe and Other Selected Countries

Thu, 20 Apr 2017 08:00:00 EDT

PARMA, ITALY--(Marketwired - April 20, 2017) - Chiesi Farmaceutici Spa ("Chiesi") acknowledges that uniQure biopharma B.V (uniQure), have taken the decision to withdraw the ongoing application for the Marketing Authorization Renewal of Glybera, for which Chiesi holds commercialization rights for Europe and other selected countries. This request for withdrawal, which is taken unilaterally by uniQure, has not been triggered by grounds on quality, safety and/or efficacy of the product but it is associated with uniQure's own economic considerations.




The New Gold Standards of IRT Delivery for Clinical Trials, New Webinar Hosted by Xtalks

Thu, 20 Apr 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - April 20, 2017) - In a live presentation, Grant Dietrich, industry expert and Vice President of Strategic Partnerships at YPrime will discuss how emerging IRT system functionality goes beyond management of patient randomization and drug supply.




NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development

Thu, 20 Apr 2017 07:00:00 EDT

FORT MYERS, FL--(Marketwired - April 20, 2017) - NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today the appointment of Bill Bonello as Vice President, Treasurer, and Director of Corporate Development.




New Frontier Data & MassRoots Partner on First Cannabis Consumer Sentiment Report

Thu, 20 Apr 2017 07:00:00 EDT

WASHINGTON, DC--(Marketwired - April 20, 2017) - New Frontier Data, the authority in business intelligence for the cannabis industry, and MassRoots, Inc. (OTCQB: MSRT), one of the leading publicly-traded cannabis technology companies, are partnering to craft a first of its kind report which will extract business intelligence from cannabis consumer data.




Applied DNA Sciences Signs 5-Year Supply Agreement for Bulk DNA Manufacturing

Thu, 20 Apr 2017 05:30:00 EDT

Agreement Highlights Growth Opportunity for Company's Proprietary DNA Production Technology




SPYRUS(R) Announces Hardware "Root of Trust" Product Family Supporting Microsoft Azure IoT Hub

Thu, 20 Apr 2017 03:01:00 EDT

SPYRUS FIPS 140-2 Level 3 Certified Devices Bring Strong Authentication to SAS Token and TLS/SSL Schema Azure IoT Hub




Cosmos Holdings, Inc. Announces Full-Year 2016 Results

Wed, 19 Apr 2017 17:58:23 EDT

Revenue Improved 1,166 Percent and Gross Profit Improved 1,126 Percent Year over Year




Immunotec dépose une circulaire de sollicitation de procurations par la direction se rapportant à l'assemblée extraordinaire des actionnaires qui aura lieu le 11 mai 2017

Wed, 19 Apr 2017 14:56:55 EDT

VAUDREUIL-DORION, QUÉBEC--(Marketwired - 19 avril 2017) - Immunotec Inc. (TSX CROISSANCE:IMM) (« Immunotec » ou la « Société ») a annoncé aujourd'hui qu'elle avait déposé sa circulaire de sollicitation de procurations par la direction (la « circulaire ») auprès des autorités en valeurs mobilières compétentes en prévision de son assemblée extraordinaire des actionnaires (l'« assemblée ») qui aura lieu le jeudi 11 mai 2017 à 10 h (heure de Montréal) aux bureaux de la Société, situés au 300, rue Joseph-Carrier, Vaudeuil-Dorion (Québec). La circulaire peut être consultée sous le profil d'Immunotec à www.sedar.com.




Immunotec Files Management Proxy Circular in Connection With Special Meeting of Shareholders to be Held on May 11, 2017

Wed, 19 Apr 2017 14:55:55 EDT

VAUDREUIL-DORION, QUEBEC--(Marketwired - April 19, 2017) - Immunotec Inc. (TSX VENTURE:IMM) ("Immunotec" or the "Company") announced today that it has filed its Management Proxy Circular (the "Circular") with the relevant securities regulatory authorities in preparation for its special meeting of shareholders (the "Meeting") to be held on Thursday, May 11, 2017 at 10:00 a.m. (Montreal time) at the Company's offices located at 300 Joseph-Carrier Street, Vaudreuil-Dorion, Québec. The Circular is available under the profile of Immunotec at www.sedar.com.




vCom, Best Places to Work -- 10 Years in a Row

Wed, 19 Apr 2017 14:49:12 EDT

vCom ranked #4 in 2017 with a highly satisfied and engaged culture




Cannabis Science Senior Executives Set to Present Drug Development Initiatives to Key Stakeholders Around the World at the Upcoming Global Health Catalyst Summit at Harvard Medical School Next Week, April 28 - 30th 2017

Wed, 19 Apr 2017 13:03:01 EDT

Cannabis Science Versus Cancer and Other Malignancies and the Palliative Care and Mental Health Sessions will be live-streamed to an audience worldwide




Parvus Therapeutics Announces Exclusive Worldwide License and Collaboration Agreement for the Development and Commercialization of Its Lead Nanomedicine to Treat Type 1 Diabetes

Wed, 19 Apr 2017 12:00:00 EDT

CALGARY, AB--(Marketwired - April 19, 2017) - Parvus Therapeutics, a biopharmaceutical company developing disease-modifying nanomedicines to halt or reverse autoimmune disease without causing general immune suppression, has entered into a license and collaboration agreement with Novartis for its lead Navacim for treating type 1 diabetes. Navacims constitute a novel pharmacological class of therapeutic comprised of nanoparticles (NPs) coated with disease-relevant peptide-major histocompatibility complexes (pMHCs) that alter the behavior of disease-causing T lymphocytes. Navacims are the first biopharmaceuticals to demonstrate in preclinical models the ability to restore immune tolerance in a disease-specific manner through in vivo formation and expansion of regulatory T-cells (T-regs) without causing general immune suppression.




ViaDerma, Inc. Announces its President, Dr. Christopher Otiko's Abstract was Well Received at the DFCON Conference as the Company Completes Final Testing for its FDA Registered Viabecline for Manufacturing in the Next Several Weeks

Wed, 19 Apr 2017 11:30:00 EDT

The Company is in the Final Phase of Testing its Proprietary Viabecline Formula for Manufacturing over the Next few Weeks and once Completed Will Start Manufacturing the Product for Distribution and Sales




Robot Automates Major Lab's Test in Unexpected Way

Wed, 19 Apr 2017 09:30:00 EDT

SALT LAKE CITY, UT--(Marketwired - April 19, 2017) - A new machine/robot called the Data Matrix Scanner is going to automate a lab's procedures to test for cholesterol particles at high volume and without the messy turns and pitches of human error. This is no ordinary solution -- it is a story of solving technological challenges in modern laboratory medicine for an important test. ARUP Laboratories needed a unique fix to move that test in-house, photograph in one shot 96 test tubes on a tray with their accompanying tiny barcodes, and process 3,000 test tubes a month while tracking the number and ID for each. So lab supervisors and in-house engineers worked out their needs and had it built.




Spirax Sarco receives SC Chamber of Commerce Safety Award for top safety records

Wed, 19 Apr 2017 09:25:04 EDT

1,341 days without a lost time incident




Algae Dynamics Corp Announces Joint Venture With ARA - Avanti Rx Analytics Inc. to Formulate, Manufacture and Sell Products Utilizing Algae, Hemp & Cannabis Oils

Wed, 19 Apr 2017 09:00:00 EDT

TORONTO, ON--(Marketwired - Apr 19, 2017) - ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the "Company" or "ADC"), a company focused on the development of unique health products and pharmaceuticals utilizing cannabis, hemp and algae oils today announced a joint venture with ARA - Avanti Rx Analytics Inc. ("ARA") in a newly-formed subsidiary entity called ADC Biomedical Corp ("BIO"), the equity of which will be owned 4% and 96% by ARA and ADC, respectively. Previously, the Company had announced a memorandum of understanding with ARA with respect to strategic collaboration between the two companies. This announcement is an extension of that previously-announced collaboration.




Plandai Biotechnology Sets Aggressive Agenda for 2017

Wed, 19 Apr 2017 09:00:00 EDT

NEW YORK, NY--(Marketwired - April 19, 2017) - Plandaí Biotechnology (OTCQB: PLPL) recently presented investors with its outlook for 2017 and a number of milestones that the company plans to accomplish in 2017. Plandaí's plans are certainly aggressive and representative of the new Chief Operating Officer (COO) -- someone we feel is ideally suited to move the company forward. It didn't take long at all for the new COO, Callum Cottrell-Duffield, to put his stamp on the company's future.




Desert Oasis Healthcare Establishes Center for Research and Healthcare Innovation Featuring Altura's HCP Studies(TM) Mobile Platform

Wed, 19 Apr 2017 08:30:00 EDT

Altura's Novel Study Engagement Platform(TM) to Help Create Optimized Clinical Study Ecosystem for Patients and Healthcare Providers




NetworkNewsWire Announces Publication Highlighting Advances in Cancer Therapy

Wed, 19 Apr 2017 08:30:00 EDT

NEW YORK, NY--(Marketwired - Apr 19, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring TapImmune, Inc. (NASDAQ: TPIV), an NNW client focused on leading the field of oncology with its next-generation T-cell vaccines and novel immunotherapy platforms.




Tetra Bio-Pharma & Aphria Announce Plans for the Joint Distribution of Dried Medical Cannabis in the Maritime Provinces & Quebec

Wed, 19 Apr 2017 08:00:00 EDT

OTTAWA, ONTARIO--(Marketwired - April 19, 2017) - Tetra Bio-Pharma Inc. ("Tetra") (CSE:TBP)(CSE:TBP.CN)(OTCQB:GRPOF) and Aphria Inc. ("Aphria") (TSX:APH) (OTCQB:APHQF), announced plans today for the joint distribution of dried medical cannabis in the maritime provinces and Quebec.




Lion Biotechnologies Announces Strategic Alliance with MD Anderson Cancer Center to Conduct Clinical Trials of TILs in Multiple Solid Tumors

Wed, 19 Apr 2017 08:00:00 EDT

SAN CARLOS, CA and HOUSTON, TX--(Marketwired - April 19, 2017) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology and The University of Texas MD Anderson Cancer Center, today announced a multi-year strategic alliance agreement involving multi-arm clinical trials to evaluate the safety and efficacy of TIL therapy in ovarian cancer, various sarcomas, and pancreatic cancer. In addition, preclinical research will explore the expansion of TIL in other rare tumor types.




Tetra Bio-Pharma & Aphria Announce Plans for the Joint Distribution of Dried Medical Cannabis in the Maritime Provinces & Quebec

Wed, 19 Apr 2017 08:00:00 EDT

OTTAWA, ONTARIO--(Marketwired - April 19, 2017) - Tetra Bio-Pharma Inc. ("Tetra") (CSE:TBP) (OTCQB:GRPOF) and Aphria Inc. ("Aphria") (TSX:APH) (OTCQB:APHQF), announced plans today for the joint distribution of dried medical cannabis in the maritime provinces and Quebec.




Technology Solutions for Late Phase Research: Optimizing Real World Data Assets, New Webinar Hosted by Xtalks

Wed, 19 Apr 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - April 19, 2017) - Michael Cook, Principal of Epidemiology and Bill Row, Divisional Principal of Real World Evidence both from ICON Commercialisation and Outcomes will outline how technological innovation can be applied to late phase research studies and how the smart application of that technology can enhance use of real world data (RWD) assets. The live event will take place on Monday, May 1, 2017 at 11am EDT (4pm BST/UK).




Amedica Announces Delayed Filing of Annual Report on Form 10-K and Receipt of Nasdaq Letter

Wed, 19 Apr 2017 07:00:00 EDT

SALT LAKE CITY, UT--(Marketwired - Apr 19, 2017) - Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, announced today that it is delaying the filing of its Annual Report on Form 10-K for the year ended December 31, 2016 ("Form 10-K").




ContraFect to Present New Data at the 27th European Congress of Clinical Microbiology and Infectious Disease (ECCMID)

Wed, 19 Apr 2017 07:00:00 EDT

YONKERS, NY--(Marketwired - April 19, 2017) - ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announces the presentation of new data from its Phase 1 CF-301 study at the 27th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) to be held on April 22-25, 2017 in Vienna, Austria.




Dr. David Kuppersmith Joins The Steadman Clinic Staff

Wed, 19 Apr 2017 06:00:00 EDT

Internal Medicine Physician joins Clinic's lengthy list of world-renowned surgeons